piracetam has been researched along with Hemosiderosis in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Hemosiderosis: Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the MONONUCLEAR PHAGOCYTE SYSTEM, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García Estévez, DA | 1 |
| García-Dorrego, RM | 1 |
| Nieto-Baltar, B | 1 |
| Marey-Garrido, M | 1 |
| Hierro-Torner, T | 1 |
1 other study available for piracetam and Hemosiderosis
| Article | Year |
|---|---|
Spontaneous convexity subarachnoid haemorrhage: Clinical series of 3 patients with associated cerebral amyloid angiopathy.
Topics: Aged; Anticonvulsants; Brain; Cerebral Amyloid Angiopathy; Dexamethasone; Female; Glucocorticoids; H | 2017 |